10 completed, 3 recruiting. 13 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 13 | Completed 10, Recruiting 3 |
Follow Turner Syndrome: new trials by email Literature Review of Turner Syndrome trials Research Report on Turner Syndrome
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Bleeding Patterns in Sequential and Continuous Progesterone Supplementation in Adolescents With Turner Syndrome Micronized progesterone 200 MG, Micronized Progesterone 100 MG - Turner Syndrome, Primary Ovarian Insufficiency (Poi) | Phase 4 | Recruiting | Children's Mercy Hospital Kansas City | 40 | 2025-07-31 | 2026-08-25 |
| Long Term Effects of Oral Versus Transdermal Estrogen Replacement Therapy in Turner Syndrome 17-beta estradiol - Turner Syndrome, Hypogonadism; Ovarian | Phase 4 | Recruiting | Aarhus University Hospital | 50 | 2021-11-29 | 2024-08-26 |
| Determining Dose Equivalence Between Oral and Transdermal Estrogen Treatment in Women With Turner Syndrome 17-beta estradiol - Turner Syndrome, Hypogonadism; Ovarian | Phase 4 | Recruiting | Aarhus University Hospital | 50 | 2021-11-29 | 2024-08-23 |
| Evaluation of the Ease of Use, Preference, and Safety of EutropinPen Inj. Somatropin - Short Stature, Idiopathic, Infant, Small for Gestational Age | Phase 4 | Completed | LG Life Sciences | 116 | 2016-08-11 | 2019-01-03 |
| First Year Growth Response Associated Genetic Markers Validation Phase IV Open-label Study in Growth Hormone Deficient and Turner Syndrome Pre-pubertal Children: the PREDICT Pharmacogenetics Validation Study Blood sampling - Idiopathic Growth Hormone Deficiency, Turner Syndrome | Phase 4 | Completed | Merck KGaA, Darmstadt, Germany | 458 | 2011-09-01 | 2014-01-16 |
| Norditropin NordiFlex® Device Compared to the Device Previously Used by Patients or Parents Norditropin NordiFlex® - Growth Hormone Disorder, Growth Hormone Deficiency in Children | Phase 4 | Completed | Novo Nordisk A/S | 103 | 2010-11-01 | 2017-02-27 |
| Estrogen Dosing in Turner Syndrome: Pharmacology and Metabolism 17 B estradiol orally, 17 B estradiol - Turner Syndrome, Hypogonadism | Phase 4 | Completed | Nemours Children's Clinic | 41 | 2009-01-01 | 2023-05-16 |
| Long-Term Growth and Skeletal Effects of Early Growth Hormone Treatment in Turner Syndrome Humatrope - Turner Syndrome | Phase 4 | Completed | Eli Lilly and Company | 69 | 2005-12-01 | 2017-03-31 |
| Defining the Optimal Hormonal Replacement Therapy in Turner Syndrome estradiol - Turner Syndrome | Phase 4 | Completed | Line Cleemann | 43 | 2005-06-01 | 2013-06-14 |
| Predictive Markers in Growth Hormone Deficiency (GHD) and Turner Syndrome (TS) Children Treated With SAIZEN® Saizen - Growth Hormone Deficiency, Turner Syndrome | Phase 4 | Completed | Merck KGaA, Darmstadt, Germany | 318 | 2005-05-31 | 2018-06-26 |
| Growth Response in Girls With Turner Syndrome somatropin - Genetic Disorder, Turner Syndrome | Phase 4 | Completed | Novo Nordisk A/S | 31 | 1996-09-23 | 2017-02-28 |
| Growth Hormone Treatment for the Prevention of Short Stature in Young Girls With Turner Syndrome Before the Age of 4 Years r-hGH - Turner's Syndrome | Phase 4 | Completed | Merck KGaA, Darmstadt, Germany | 115 | 1992-02-29 | 2018-12-14 |
| Safety of Somatropin and Induction of Puberty With 17-beta-oestradiol in Girls With Turner Syndrome somatropin, oestrogen - Genetic Disorder, Turner Syndrome | Phase 4 | Completed | Novo Nordisk A/S | 65 | 1989-11-01 | 2017-01-18 |
Dwarfism, Pituitary (3) · Genetic Diseases, Inborn (3) · Hypogonadism (3) · Primary Ovarian Insufficiency (2) · Dwarfism (1) · Kidney Failure, Chronic (1) · Renal Insufficiency, Chronic (1)
Cardiovascular Abnormalities (13) · Cardiovascular Diseases (13) · Chromosome Disorders (13) · Congenital Abnormalities (13) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (13) · Disorders of Sex Development (13) · Endocrine System Diseases (13) · Female Urogenital Diseases (13) · Female Urogenital Diseases and Pregnancy Complications (13) · Gonadal Disorders (13) · Gonadal Dysgenesis (13) · Heart Defects, Congenital (13) · Heart Diseases (13) · Male Urogenital Diseases (13) · Sex Chromosome Disorders (13)
Human Growth Hormone (6) · Estradiol (4) · estradiol, estriol drug combination (2) · Blood Specimen Collection (1) · Estrogens (1) · Growth Hormone (1) · Progesterone (1)
Merck KGaA, Darmstadt, Germany (3) · Novo Nordisk A/S (3) · Aarhus University Hospital (2) · Children's Mercy Hospital Kansas City (1) · Eli Lilly and Company (1) · LG Life Sciences (1) · Line Cleemann (1) · Nemours Children's Clinic (1)
France (5) · Denmark (3) · United States (3) · Argentina (2) · Canada (2) · Germany (2) · Italy (2) · Spain (2) · Sweden (2) · United Kingdom (2) · Australia (1) · Austria (1) · Chile (1) · Czechia (1) · Netherlands (1)
Claus H Gravholt, Professor (2) · Gilles Della Corte (1) · Line Cleemann, Doctor (1) · Nelly Mauras, MD (1) · Tazim Dowlut-McElroy, M.D., M.S. (1)
PMID 10518081, PMID 10599727, PMID 10599729, PMID 12466334, PMID 12629094, PMID 15900109, PMID 21398400, PMID 21880799, PMID 23567489, PMID 23678038, PMID 23737664, PMID 26340968, PMID 29618660, PMID 30571546, PMID 31613320, PMID 31908426, PMID 34045667, PMID 8923853
2009 (1)